Atlas Trials

A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster

Clinical trial NCT05602961 · WITHDRAWN

Trial details

NCT number
NCT05602961
Sponsor
GreenLight Biosciences, Inc.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2023-02-21
Primary completion
2024-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.